nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—Cytochrome P450 3A Inducers—Phenytoin—epilepsy syndrome	0.208	0.36	CiPCiCtD
Nevirapine—Cytochrome P450 2B6 Inducers—Carbamazepine—epilepsy syndrome	0.195	0.338	CiPCiCtD
Nevirapine—Cytochrome P450 2B6 Inducers—Phenytoin—epilepsy syndrome	0.174	0.301	CiPCiCtD
Nevirapine—CYP2D6—epilepsy syndrome	0.0707	1	CbGaD
Nevirapine—CYP2A6—Amobarbital—epilepsy syndrome	0.0137	0.0524	CbGbCtD
Nevirapine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.011	0.0423	CbGbCtD
Nevirapine—CYP2A6—Propofol—epilepsy syndrome	0.0102	0.0391	CbGbCtD
Nevirapine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00995	0.0382	CbGbCtD
Nevirapine—CYP2A6—Phenobarbital—epilepsy syndrome	0.00974	0.0373	CbGbCtD
Nevirapine—CYP2B6—Clobazam—epilepsy syndrome	0.00958	0.0367	CbGbCtD
Nevirapine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00793	0.0304	CbGbCtD
Nevirapine—CYP2B6—Primidone—epilepsy syndrome	0.00741	0.0284	CbGbCtD
Nevirapine—CYP2A6—Valproic Acid—epilepsy syndrome	0.00728	0.0279	CbGbCtD
Nevirapine—CYP2B6—Phenytoin—epilepsy syndrome	0.00712	0.0273	CbGbCtD
Nevirapine—CYP2B6—Propofol—epilepsy syndrome	0.00664	0.0254	CbGbCtD
Nevirapine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00634	0.0243	CbGbCtD
Nevirapine—CYP2B6—Midazolam—epilepsy syndrome	0.00625	0.024	CbGbCtD
Nevirapine—CYP3A5—Carbamazepine—epilepsy syndrome	0.00625	0.024	CbGbCtD
Nevirapine—CYP2C9—Trimethadione—epilepsy syndrome	0.00621	0.0238	CbGbCtD
Nevirapine—CYP2B6—Diazepam—epilepsy syndrome	0.00601	0.023	CbGbCtD
Nevirapine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00583	0.0224	CbGbCtD
Nevirapine—CYP3A5—Phenytoin—epilepsy syndrome	0.00561	0.0215	CbGbCtD
Nevirapine—CYP3A5—Phenobarbital—epilepsy syndrome	0.005	0.0192	CbGbCtD
Nevirapine—CYP3A5—Midazolam—epilepsy syndrome	0.00493	0.0189	CbGbCtD
Nevirapine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00474	0.0182	CbGbCtD
Nevirapine—CYP3A5—Diazepam—epilepsy syndrome	0.00474	0.0182	CbGbCtD
Nevirapine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00465	0.0178	CbGbCtD
Nevirapine—CYP1A2—Primidone—epilepsy syndrome	0.00434	0.0166	CbGbCtD
Nevirapine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00419	0.0161	CbGbCtD
Nevirapine—CYP2C9—Primidone—epilepsy syndrome	0.00391	0.015	CbGbCtD
Nevirapine—CYP1A2—Propofol—epilepsy syndrome	0.00389	0.0149	CbGbCtD
Nevirapine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00388	0.0149	CbGbCtD
Nevirapine—CYP2C9—Phenytoin—epilepsy syndrome	0.00376	0.0144	CbGbCtD
Nevirapine—CYP3A5—Valproic Acid—epilepsy syndrome	0.00373	0.0143	CbGbCtD
Nevirapine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00372	0.0143	CbGbCtD
Nevirapine—CYP3A4—Felbamate—epilepsy syndrome	0.00361	0.0138	CbGbCtD
Nevirapine—CYP3A4—Trimethadione—epilepsy syndrome	0.00361	0.0138	CbGbCtD
Nevirapine—CYP1A2—Diazepam—epilepsy syndrome	0.00353	0.0135	CbGbCtD
Nevirapine—CYP2C9—Propofol—epilepsy syndrome	0.00351	0.0134	CbGbCtD
Nevirapine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00339	0.013	CbGbCtD
Nevirapine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00335	0.0128	CbGbCtD
Nevirapine—CYP2D6—Propofol—epilepsy syndrome	0.00321	0.0123	CbGbCtD
Nevirapine—CYP2C9—Diazepam—epilepsy syndrome	0.00318	0.0122	CbGbCtD
Nevirapine—CYP3A4—Clonazepam—epilepsy syndrome	0.00307	0.0118	CbGbCtD
Nevirapine—CYP3A4—Clobazam—epilepsy syndrome	0.00294	0.0113	CbGbCtD
Nevirapine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00278	0.0107	CbGbCtD
Nevirapine—CYP2C9—Valproic Acid—epilepsy syndrome	0.0025	0.0096	CbGbCtD
Nevirapine—CYP3A4—Rufinamide—epilepsy syndrome	0.0025	0.00959	CbGbCtD
Nevirapine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00244	0.00934	CbGbCtD
Nevirapine—CYP3A4—Primidone—epilepsy syndrome	0.00228	0.00872	CbGbCtD
Nevirapine—CYP3A4—Phenytoin—epilepsy syndrome	0.00219	0.00838	CbGbCtD
Nevirapine—CYP3A4—Propofol—epilepsy syndrome	0.00204	0.00781	CbGbCtD
Nevirapine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00195	0.00747	CbGbCtD
Nevirapine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00195	0.00747	CbGbCtD
Nevirapine—CYP3A4—Midazolam—epilepsy syndrome	0.00192	0.00736	CbGbCtD
Nevirapine—CYP3A4—Diazepam—epilepsy syndrome	0.00185	0.00708	CbGbCtD
Nevirapine—CYP3A4—Zonisamide—epilepsy syndrome	0.0018	0.00691	CbGbCtD
Nevirapine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00146	0.00558	CbGbCtD
Nevirapine—CYP3A4—Topiramate—epilepsy syndrome	0.00131	0.00504	CbGbCtD
Nevirapine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.00048	CcSEcCtD
Nevirapine—Diarrhoea—Fosphenytoin—epilepsy syndrome	3.75e-05	0.00048	CcSEcCtD
Nevirapine—Neuropathy peripheral—Topiramate—epilepsy syndrome	3.74e-05	0.000479	CcSEcCtD
Nevirapine—Vomiting—Propofol—epilepsy syndrome	3.73e-05	0.000478	CcSEcCtD
Nevirapine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	3.72e-05	0.000476	CcSEcCtD
Nevirapine—Pruritus—Diazepam—epilepsy syndrome	3.72e-05	0.000476	CcSEcCtD
Nevirapine—Conjunctivitis—Topiramate—epilepsy syndrome	3.71e-05	0.000475	CcSEcCtD
Nevirapine—Rash—Propofol—epilepsy syndrome	3.7e-05	0.000474	CcSEcCtD
Nevirapine—Dermatitis—Propofol—epilepsy syndrome	3.7e-05	0.000473	CcSEcCtD
Nevirapine—Immune system disorder—Gabapentin—epilepsy syndrome	3.68e-05	0.000471	CcSEcCtD
Nevirapine—Headache—Propofol—epilepsy syndrome	3.68e-05	0.000471	CcSEcCtD
Nevirapine—Hypersensitivity—Zonisamide—epilepsy syndrome	3.67e-05	0.000469	CcSEcCtD
Nevirapine—Vomiting—Midazolam—epilepsy syndrome	3.65e-05	0.000468	CcSEcCtD
Nevirapine—Diarrhoea—Vigabatrin—epilepsy syndrome	3.65e-05	0.000467	CcSEcCtD
Nevirapine—Asthenia—Felbamate—epilepsy syndrome	3.65e-05	0.000467	CcSEcCtD
Nevirapine—Myalgia—Valproic Acid—epilepsy syndrome	3.64e-05	0.000466	CcSEcCtD
Nevirapine—Arthralgia—Valproic Acid—epilepsy syndrome	3.64e-05	0.000466	CcSEcCtD
Nevirapine—Feeling abnormal—Lamotrigine—epilepsy syndrome	3.62e-05	0.000464	CcSEcCtD
Nevirapine—Rash—Midazolam—epilepsy syndrome	3.62e-05	0.000464	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	3.62e-05	0.000463	CcSEcCtD
Nevirapine—Dermatitis—Midazolam—epilepsy syndrome	3.62e-05	0.000463	CcSEcCtD
Nevirapine—Urticaria—Carbamazepine—epilepsy syndrome	3.61e-05	0.000463	CcSEcCtD
Nevirapine—Vomiting—Levetiracetam—epilepsy syndrome	3.61e-05	0.000462	CcSEcCtD
Nevirapine—Discomfort—Valproic Acid—epilepsy syndrome	3.6e-05	0.000461	CcSEcCtD
Nevirapine—Headache—Midazolam—epilepsy syndrome	3.6e-05	0.000461	CcSEcCtD
Nevirapine—Pruritus—Felbamate—epilepsy syndrome	3.6e-05	0.000461	CcSEcCtD
Nevirapine—Abdominal pain—Carbamazepine—epilepsy syndrome	3.6e-05	0.00046	CcSEcCtD
Nevirapine—Body temperature increased—Carbamazepine—epilepsy syndrome	3.6e-05	0.00046	CcSEcCtD
Nevirapine—Diarrhoea—Diazepam—epilepsy syndrome	3.6e-05	0.00046	CcSEcCtD
Nevirapine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	3.6e-05	0.00046	CcSEcCtD
Nevirapine—Ill-defined disorder—Pregabalin—epilepsy syndrome	3.59e-05	0.00046	CcSEcCtD
Nevirapine—Rash—Levetiracetam—epilepsy syndrome	3.58e-05	0.000458	CcSEcCtD
Nevirapine—Anaemia—Pregabalin—epilepsy syndrome	3.58e-05	0.000458	CcSEcCtD
Nevirapine—Dermatitis—Levetiracetam—epilepsy syndrome	3.57e-05	0.000457	CcSEcCtD
Nevirapine—Asthenia—Zonisamide—epilepsy syndrome	3.57e-05	0.000457	CcSEcCtD
Nevirapine—Agranulocytosis—Topiramate—epilepsy syndrome	3.57e-05	0.000456	CcSEcCtD
Nevirapine—Headache—Levetiracetam—epilepsy syndrome	3.55e-05	0.000455	CcSEcCtD
Nevirapine—Erythema—Gabapentin—epilepsy syndrome	3.55e-05	0.000454	CcSEcCtD
Nevirapine—Angioedema—Pregabalin—epilepsy syndrome	3.54e-05	0.000453	CcSEcCtD
Nevirapine—Hypersensitivity—Clonazepam—epilepsy syndrome	3.53e-05	0.000452	CcSEcCtD
Nevirapine—Pruritus—Zonisamide—epilepsy syndrome	3.52e-05	0.000451	CcSEcCtD
Nevirapine—Hypersensitivity—Phenytoin—epilepsy syndrome	3.51e-05	0.000449	CcSEcCtD
Nevirapine—Oedema—Valproic Acid—epilepsy syndrome	3.49e-05	0.000447	CcSEcCtD
Nevirapine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.49e-05	0.000447	CcSEcCtD
Nevirapine—Urticaria—Lamotrigine—epilepsy syndrome	3.49e-05	0.000447	CcSEcCtD
Nevirapine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.49e-05	0.000447	CcSEcCtD
Nevirapine—Malaise—Pregabalin—epilepsy syndrome	3.49e-05	0.000447	CcSEcCtD
Nevirapine—Nausea—Propofol—epilepsy syndrome	3.49e-05	0.000446	CcSEcCtD
Nevirapine—Vomiting—Fosphenytoin—epilepsy syndrome	3.48e-05	0.000446	CcSEcCtD
Nevirapine—Diarrhoea—Felbamate—epilepsy syndrome	3.48e-05	0.000445	CcSEcCtD
Nevirapine—Abdominal pain—Lamotrigine—epilepsy syndrome	3.48e-05	0.000445	CcSEcCtD
Nevirapine—Body temperature increased—Lamotrigine—epilepsy syndrome	3.48e-05	0.000445	CcSEcCtD
Nevirapine—Rash—Fosphenytoin—epilepsy syndrome	3.45e-05	0.000442	CcSEcCtD
Nevirapine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.45e-05	0.000441	CcSEcCtD
Nevirapine—Asthenia—Clonazepam—epilepsy syndrome	3.44e-05	0.000441	CcSEcCtD
Nevirapine—Headache—Fosphenytoin—epilepsy syndrome	3.43e-05	0.000439	CcSEcCtD
Nevirapine—Hepatitis—Topiramate—epilepsy syndrome	3.43e-05	0.000439	CcSEcCtD
Nevirapine—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.43e-05	0.000439	CcSEcCtD
Nevirapine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.42e-05	0.000438	CcSEcCtD
Nevirapine—Asthenia—Phenytoin—epilepsy syndrome	3.42e-05	0.000438	CcSEcCtD
Nevirapine—Nausea—Midazolam—epilepsy syndrome	3.41e-05	0.000437	CcSEcCtD
Nevirapine—Diarrhoea—Zonisamide—epilepsy syndrome	3.41e-05	0.000436	CcSEcCtD
Nevirapine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.4e-05	0.000435	CcSEcCtD
Nevirapine—Pruritus—Clonazepam—epilepsy syndrome	3.39e-05	0.000434	CcSEcCtD
Nevirapine—Vomiting—Vigabatrin—epilepsy syndrome	3.39e-05	0.000434	CcSEcCtD
Nevirapine—Skin disorder—Valproic Acid—epilepsy syndrome	3.39e-05	0.000434	CcSEcCtD
Nevirapine—Pruritus—Phenytoin—epilepsy syndrome	3.37e-05	0.000432	CcSEcCtD
Nevirapine—Connective tissue disorder—Topiramate—epilepsy syndrome	3.37e-05	0.000431	CcSEcCtD
Nevirapine—Nausea—Levetiracetam—epilepsy syndrome	3.37e-05	0.000431	CcSEcCtD
Nevirapine—Rash—Vigabatrin—epilepsy syndrome	3.37e-05	0.000431	CcSEcCtD
Nevirapine—Dermatitis—Vigabatrin—epilepsy syndrome	3.36e-05	0.00043	CcSEcCtD
Nevirapine—Pruritus—Oxcarbazepine—epilepsy syndrome	3.35e-05	0.000429	CcSEcCtD
Nevirapine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.35e-05	0.000429	CcSEcCtD
Nevirapine—Headache—Vigabatrin—epilepsy syndrome	3.34e-05	0.000428	CcSEcCtD
Nevirapine—Vomiting—Diazepam—epilepsy syndrome	3.34e-05	0.000428	CcSEcCtD
Nevirapine—Anorexia—Valproic Acid—epilepsy syndrome	3.33e-05	0.000426	CcSEcCtD
Nevirapine—Rash—Diazepam—epilepsy syndrome	3.31e-05	0.000424	CcSEcCtD
Nevirapine—Dermatitis—Diazepam—epilepsy syndrome	3.31e-05	0.000424	CcSEcCtD
Nevirapine—Arthralgia—Pregabalin—epilepsy syndrome	3.29e-05	0.000422	CcSEcCtD
Nevirapine—Myalgia—Pregabalin—epilepsy syndrome	3.29e-05	0.000422	CcSEcCtD
Nevirapine—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.29e-05	0.000421	CcSEcCtD
Nevirapine—Headache—Diazepam—epilepsy syndrome	3.29e-05	0.000421	CcSEcCtD
Nevirapine—Diarrhoea—Clonazepam—epilepsy syndrome	3.28e-05	0.00042	CcSEcCtD
Nevirapine—Anaemia—Gabapentin—epilepsy syndrome	3.28e-05	0.00042	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.27e-05	0.000419	CcSEcCtD
Nevirapine—Asthenia—Carbamazepine—epilepsy syndrome	3.26e-05	0.000418	CcSEcCtD
Nevirapine—Diarrhoea—Phenytoin—epilepsy syndrome	3.26e-05	0.000417	CcSEcCtD
Nevirapine—Discomfort—Pregabalin—epilepsy syndrome	3.26e-05	0.000417	CcSEcCtD
Nevirapine—Nausea—Fosphenytoin—epilepsy syndrome	3.25e-05	0.000416	CcSEcCtD
Nevirapine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.000415	CcSEcCtD
Nevirapine—Erythema multiforme—Topiramate—epilepsy syndrome	3.24e-05	0.000415	CcSEcCtD
Nevirapine—Angioedema—Gabapentin—epilepsy syndrome	3.24e-05	0.000415	CcSEcCtD
Nevirapine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.24e-05	0.000415	CcSEcCtD
Nevirapine—Vomiting—Felbamate—epilepsy syndrome	3.23e-05	0.000414	CcSEcCtD
Nevirapine—Pruritus—Carbamazepine—epilepsy syndrome	3.22e-05	0.000412	CcSEcCtD
Nevirapine—Rash—Felbamate—epilepsy syndrome	3.21e-05	0.00041	CcSEcCtD
Nevirapine—Dermatitis—Felbamate—epilepsy syndrome	3.2e-05	0.00041	CcSEcCtD
Nevirapine—Malaise—Gabapentin—epilepsy syndrome	3.2e-05	0.00041	CcSEcCtD
Nevirapine—Headache—Felbamate—epilepsy syndrome	3.19e-05	0.000408	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.18e-05	0.000407	CcSEcCtD
Nevirapine—Nausea—Vigabatrin—epilepsy syndrome	3.17e-05	0.000406	CcSEcCtD
Nevirapine—Vomiting—Zonisamide—epilepsy syndrome	3.17e-05	0.000405	CcSEcCtD
Nevirapine—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.16e-05	0.000404	CcSEcCtD
Nevirapine—Oedema—Pregabalin—epilepsy syndrome	3.16e-05	0.000404	CcSEcCtD
Nevirapine—Asthenia—Lamotrigine—epilepsy syndrome	3.15e-05	0.000404	CcSEcCtD
Nevirapine—Rash—Zonisamide—epilepsy syndrome	3.14e-05	0.000402	CcSEcCtD
Nevirapine—Paraesthesia—Valproic Acid—epilepsy syndrome	3.14e-05	0.000402	CcSEcCtD
Nevirapine—Dermatitis—Zonisamide—epilepsy syndrome	3.14e-05	0.000401	CcSEcCtD
Nevirapine—Nausea—Diazepam—epilepsy syndrome	3.12e-05	0.000399	CcSEcCtD
Nevirapine—Headache—Zonisamide—epilepsy syndrome	3.12e-05	0.000399	CcSEcCtD
Nevirapine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.11e-05	0.000398	CcSEcCtD
Nevirapine—Pruritus—Lamotrigine—epilepsy syndrome	3.11e-05	0.000398	CcSEcCtD
Nevirapine—Somnolence—Valproic Acid—epilepsy syndrome	3.11e-05	0.000398	CcSEcCtD
Nevirapine—Immune system disorder—Topiramate—epilepsy syndrome	3.1e-05	0.000396	CcSEcCtD
Nevirapine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.1e-05	0.000396	CcSEcCtD
Nevirapine—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.09e-05	0.000396	CcSEcCtD
Nevirapine—Skin disorder—Pregabalin—epilepsy syndrome	3.07e-05	0.000393	CcSEcCtD
Nevirapine—Vomiting—Clonazepam—epilepsy syndrome	3.05e-05	0.00039	CcSEcCtD
Nevirapine—Decreased appetite—Valproic Acid—epilepsy syndrome	3.04e-05	0.000389	CcSEcCtD
Nevirapine—Vomiting—Phenytoin—epilepsy syndrome	3.03e-05	0.000388	CcSEcCtD
Nevirapine—Rash—Clonazepam—epilepsy syndrome	3.03e-05	0.000387	CcSEcCtD
Nevirapine—Dermatitis—Clonazepam—epilepsy syndrome	3.02e-05	0.000387	CcSEcCtD
Nevirapine—Myalgia—Gabapentin—epilepsy syndrome	3.02e-05	0.000387	CcSEcCtD
Nevirapine—Arthralgia—Gabapentin—epilepsy syndrome	3.02e-05	0.000387	CcSEcCtD
Nevirapine—Nausea—Felbamate—epilepsy syndrome	3.02e-05	0.000387	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.02e-05	0.000386	CcSEcCtD
Nevirapine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.01e-05	0.000386	CcSEcCtD
Nevirapine—Fatigue—Valproic Acid—epilepsy syndrome	3.01e-05	0.000386	CcSEcCtD
Nevirapine—Anorexia—Pregabalin—epilepsy syndrome	3.01e-05	0.000385	CcSEcCtD
Nevirapine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.01e-05	0.000385	CcSEcCtD
Nevirapine—Headache—Clonazepam—epilepsy syndrome	3.01e-05	0.000385	CcSEcCtD
Nevirapine—Rash—Phenytoin—epilepsy syndrome	3e-05	0.000385	CcSEcCtD
Nevirapine—Dermatitis—Phenytoin—epilepsy syndrome	3e-05	0.000384	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3e-05	0.000384	CcSEcCtD
Nevirapine—Rash—Oxcarbazepine—epilepsy syndrome	2.99e-05	0.000383	CcSEcCtD
Nevirapine—Pain—Valproic Acid—epilepsy syndrome	2.99e-05	0.000382	CcSEcCtD
Nevirapine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.99e-05	0.000382	CcSEcCtD
Nevirapine—Headache—Phenytoin—epilepsy syndrome	2.99e-05	0.000382	CcSEcCtD
Nevirapine—Erythema—Topiramate—epilepsy syndrome	2.99e-05	0.000382	CcSEcCtD
Nevirapine—Discomfort—Gabapentin—epilepsy syndrome	2.98e-05	0.000382	CcSEcCtD
Nevirapine—Headache—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.00038	CcSEcCtD
Nevirapine—Nausea—Zonisamide—epilepsy syndrome	2.96e-05	0.000378	CcSEcCtD
Nevirapine—Oedema—Gabapentin—epilepsy syndrome	2.9e-05	0.000371	CcSEcCtD
Nevirapine—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.9e-05	0.000371	CcSEcCtD
Nevirapine—Vomiting—Carbamazepine—epilepsy syndrome	2.89e-05	0.00037	CcSEcCtD
Nevirapine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.88e-05	0.000368	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.88e-05	0.000368	CcSEcCtD
Nevirapine—Rash—Carbamazepine—epilepsy syndrome	2.87e-05	0.000367	CcSEcCtD
Nevirapine—Dermatitis—Carbamazepine—epilepsy syndrome	2.87e-05	0.000367	CcSEcCtD
Nevirapine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.86e-05	0.000366	CcSEcCtD
Nevirapine—Nausea—Clonazepam—epilepsy syndrome	2.85e-05	0.000365	CcSEcCtD
Nevirapine—Headache—Carbamazepine—epilepsy syndrome	2.85e-05	0.000365	CcSEcCtD
Nevirapine—Nervous system disorder—Gabapentin—epilepsy syndrome	2.84e-05	0.000364	CcSEcCtD
Nevirapine—Paraesthesia—Pregabalin—epilepsy syndrome	2.84e-05	0.000363	CcSEcCtD
Nevirapine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.84e-05	0.000363	CcSEcCtD
Nevirapine—Nausea—Phenytoin—epilepsy syndrome	2.83e-05	0.000362	CcSEcCtD
Nevirapine—Nausea—Oxcarbazepine—epilepsy syndrome	2.82e-05	0.00036	CcSEcCtD
Nevirapine—Skin disorder—Gabapentin—epilepsy syndrome	2.81e-05	0.00036	CcSEcCtD
Nevirapine—Somnolence—Pregabalin—epilepsy syndrome	2.81e-05	0.000359	CcSEcCtD
Nevirapine—Vomiting—Lamotrigine—epilepsy syndrome	2.8e-05	0.000358	CcSEcCtD
Nevirapine—Urticaria—Valproic Acid—epilepsy syndrome	2.78e-05	0.000355	CcSEcCtD
Nevirapine—Rash—Lamotrigine—epilepsy syndrome	2.77e-05	0.000355	CcSEcCtD
Nevirapine—Ill-defined disorder—Topiramate—epilepsy syndrome	2.77e-05	0.000355	CcSEcCtD
Nevirapine—Dermatitis—Lamotrigine—epilepsy syndrome	2.77e-05	0.000354	CcSEcCtD
Nevirapine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.76e-05	0.000353	CcSEcCtD
Nevirapine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.76e-05	0.000353	CcSEcCtD
Nevirapine—Anorexia—Gabapentin—epilepsy syndrome	2.76e-05	0.000353	CcSEcCtD
Nevirapine—Anaemia—Topiramate—epilepsy syndrome	2.76e-05	0.000353	CcSEcCtD
Nevirapine—Headache—Lamotrigine—epilepsy syndrome	2.75e-05	0.000353	CcSEcCtD
Nevirapine—Decreased appetite—Pregabalin—epilepsy syndrome	2.75e-05	0.000351	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.73e-05	0.000349	CcSEcCtD
Nevirapine—Fatigue—Pregabalin—epilepsy syndrome	2.72e-05	0.000349	CcSEcCtD
Nevirapine—Nausea—Carbamazepine—epilepsy syndrome	2.7e-05	0.000346	CcSEcCtD
Nevirapine—Pain—Pregabalin—epilepsy syndrome	2.7e-05	0.000346	CcSEcCtD
Nevirapine—Malaise—Topiramate—epilepsy syndrome	2.69e-05	0.000345	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.64e-05	0.000338	CcSEcCtD
Nevirapine—Nausea—Lamotrigine—epilepsy syndrome	2.61e-05	0.000334	CcSEcCtD
Nevirapine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.6e-05	0.000333	CcSEcCtD
Nevirapine—Paraesthesia—Gabapentin—epilepsy syndrome	2.6e-05	0.000333	CcSEcCtD
Nevirapine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.58e-05	0.000331	CcSEcCtD
Nevirapine—Somnolence—Gabapentin—epilepsy syndrome	2.57e-05	0.00033	CcSEcCtD
Nevirapine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.57e-05	0.000329	CcSEcCtD
Nevirapine—Myalgia—Topiramate—epilepsy syndrome	2.54e-05	0.000325	CcSEcCtD
Nevirapine—Arthralgia—Topiramate—epilepsy syndrome	2.54e-05	0.000325	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.52e-05	0.000323	CcSEcCtD
Nevirapine—Decreased appetite—Gabapentin—epilepsy syndrome	2.52e-05	0.000322	CcSEcCtD
Nevirapine—Discomfort—Topiramate—epilepsy syndrome	2.51e-05	0.000321	CcSEcCtD
Nevirapine—Urticaria—Pregabalin—epilepsy syndrome	2.51e-05	0.000321	CcSEcCtD
Nevirapine—Asthenia—Valproic Acid—epilepsy syndrome	2.51e-05	0.000321	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.5e-05	0.00032	CcSEcCtD
Nevirapine—Fatigue—Gabapentin—epilepsy syndrome	2.5e-05	0.00032	CcSEcCtD
Nevirapine—Body temperature increased—Pregabalin—epilepsy syndrome	2.5e-05	0.00032	CcSEcCtD
Nevirapine—Abdominal pain—Pregabalin—epilepsy syndrome	2.5e-05	0.00032	CcSEcCtD
Nevirapine—Pain—Gabapentin—epilepsy syndrome	2.48e-05	0.000317	CcSEcCtD
Nevirapine—Pruritus—Valproic Acid—epilepsy syndrome	2.47e-05	0.000316	CcSEcCtD
Nevirapine—Oedema—Topiramate—epilepsy syndrome	2.44e-05	0.000312	CcSEcCtD
Nevirapine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.39e-05	0.000306	CcSEcCtD
Nevirapine—Nervous system disorder—Topiramate—epilepsy syndrome	2.39e-05	0.000306	CcSEcCtD
Nevirapine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.39e-05	0.000305	CcSEcCtD
Nevirapine—Thrombocytopenia—Topiramate—epilepsy syndrome	2.39e-05	0.000305	CcSEcCtD
Nevirapine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.37e-05	0.000303	CcSEcCtD
Nevirapine—Skin disorder—Topiramate—epilepsy syndrome	2.37e-05	0.000303	CcSEcCtD
Nevirapine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.33e-05	0.000298	CcSEcCtD
Nevirapine—Anorexia—Topiramate—epilepsy syndrome	2.32e-05	0.000297	CcSEcCtD
Nevirapine—Urticaria—Gabapentin—epilepsy syndrome	2.3e-05	0.000294	CcSEcCtD
Nevirapine—Abdominal pain—Gabapentin—epilepsy syndrome	2.29e-05	0.000293	CcSEcCtD
Nevirapine—Body temperature increased—Gabapentin—epilepsy syndrome	2.29e-05	0.000293	CcSEcCtD
Nevirapine—Asthenia—Pregabalin—epilepsy syndrome	2.27e-05	0.00029	CcSEcCtD
Nevirapine—Pruritus—Pregabalin—epilepsy syndrome	2.23e-05	0.000286	CcSEcCtD
Nevirapine—Vomiting—Valproic Acid—epilepsy syndrome	2.22e-05	0.000284	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.22e-05	0.000284	CcSEcCtD
Nevirapine—Rash—Valproic Acid—epilepsy syndrome	2.2e-05	0.000282	CcSEcCtD
Nevirapine—Dermatitis—Valproic Acid—epilepsy syndrome	2.2e-05	0.000282	CcSEcCtD
Nevirapine—Headache—Valproic Acid—epilepsy syndrome	2.19e-05	0.00028	CcSEcCtD
Nevirapine—Paraesthesia—Topiramate—epilepsy syndrome	2.19e-05	0.00028	CcSEcCtD
Nevirapine—Somnolence—Topiramate—epilepsy syndrome	2.17e-05	0.000277	CcSEcCtD
Nevirapine—Diarrhoea—Pregabalin—epilepsy syndrome	2.16e-05	0.000277	CcSEcCtD
Nevirapine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.13e-05	0.000273	CcSEcCtD
Nevirapine—Decreased appetite—Topiramate—epilepsy syndrome	2.12e-05	0.000271	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.1e-05	0.000269	CcSEcCtD
Nevirapine—Fatigue—Topiramate—epilepsy syndrome	2.1e-05	0.000269	CcSEcCtD
Nevirapine—Pain—Topiramate—epilepsy syndrome	2.08e-05	0.000267	CcSEcCtD
Nevirapine—Asthenia—Gabapentin—epilepsy syndrome	2.08e-05	0.000266	CcSEcCtD
Nevirapine—Nausea—Valproic Acid—epilepsy syndrome	2.08e-05	0.000266	CcSEcCtD
Nevirapine—Pruritus—Gabapentin—epilepsy syndrome	2.05e-05	0.000262	CcSEcCtD
Nevirapine—Vomiting—Pregabalin—epilepsy syndrome	2.01e-05	0.000257	CcSEcCtD
Nevirapine—Feeling abnormal—Topiramate—epilepsy syndrome	2.01e-05	0.000257	CcSEcCtD
Nevirapine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.99e-05	0.000255	CcSEcCtD
Nevirapine—Rash—Pregabalin—epilepsy syndrome	1.99e-05	0.000255	CcSEcCtD
Nevirapine—Dermatitis—Pregabalin—epilepsy syndrome	1.99e-05	0.000255	CcSEcCtD
Nevirapine—Diarrhoea—Gabapentin—epilepsy syndrome	1.98e-05	0.000254	CcSEcCtD
Nevirapine—Headache—Pregabalin—epilepsy syndrome	1.98e-05	0.000253	CcSEcCtD
Nevirapine—Urticaria—Topiramate—epilepsy syndrome	1.94e-05	0.000248	CcSEcCtD
Nevirapine—Body temperature increased—Topiramate—epilepsy syndrome	1.93e-05	0.000247	CcSEcCtD
Nevirapine—Abdominal pain—Topiramate—epilepsy syndrome	1.93e-05	0.000247	CcSEcCtD
Nevirapine—Nausea—Pregabalin—epilepsy syndrome	1.88e-05	0.00024	CcSEcCtD
Nevirapine—Vomiting—Gabapentin—epilepsy syndrome	1.84e-05	0.000236	CcSEcCtD
Nevirapine—Rash—Gabapentin—epilepsy syndrome	1.83e-05	0.000234	CcSEcCtD
Nevirapine—Dermatitis—Gabapentin—epilepsy syndrome	1.82e-05	0.000234	CcSEcCtD
Nevirapine—Headache—Gabapentin—epilepsy syndrome	1.81e-05	0.000232	CcSEcCtD
Nevirapine—Hypersensitivity—Topiramate—epilepsy syndrome	1.8e-05	0.00023	CcSEcCtD
Nevirapine—Asthenia—Topiramate—epilepsy syndrome	1.75e-05	0.000224	CcSEcCtD
Nevirapine—Pruritus—Topiramate—epilepsy syndrome	1.72e-05	0.000221	CcSEcCtD
Nevirapine—Nausea—Gabapentin—epilepsy syndrome	1.72e-05	0.00022	CcSEcCtD
Nevirapine—Diarrhoea—Topiramate—epilepsy syndrome	1.67e-05	0.000213	CcSEcCtD
Nevirapine—Vomiting—Topiramate—epilepsy syndrome	1.55e-05	0.000198	CcSEcCtD
Nevirapine—Rash—Topiramate—epilepsy syndrome	1.54e-05	0.000197	CcSEcCtD
Nevirapine—Dermatitis—Topiramate—epilepsy syndrome	1.53e-05	0.000196	CcSEcCtD
Nevirapine—Headache—Topiramate—epilepsy syndrome	1.53e-05	0.000195	CcSEcCtD
Nevirapine—Nausea—Topiramate—epilepsy syndrome	1.45e-05	0.000185	CcSEcCtD
Nevirapine—CYP2B6—Metabolism—AQP1—epilepsy syndrome	4.55e-06	0.000324	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.5e-06	0.000321	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.5e-06	0.000321	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.5e-06	0.000321	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.5e-06	0.000321	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.5e-06	0.000321	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.5e-06	0.000321	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AQP1—epilepsy syndrome	4.45e-06	0.000317	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	4.44e-06	0.000316	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	4.44e-06	0.000316	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	4.42e-06	0.000315	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	4.42e-06	0.000315	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PFKL—epilepsy syndrome	4.42e-06	0.000315	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	4.42e-06	0.000315	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	4.42e-06	0.000315	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GBE1—epilepsy syndrome	4.4e-06	0.000314	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	4.4e-06	0.000314	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	4.32e-06	0.000308	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.3e-06	0.000307	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.3e-06	0.000306	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	4.17e-06	0.000297	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	4.16e-06	0.000296	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	4.14e-06	0.000295	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.12e-06	0.000294	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.12e-06	0.000294	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.12e-06	0.000294	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.12e-06	0.000294	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—KCNJ11—epilepsy syndrome	4.12e-06	0.000293	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CHRM3—epilepsy syndrome	4.12e-06	0.000293	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	4.06e-06	0.000289	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	4.05e-06	0.000289	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NEU1—epilepsy syndrome	4.05e-06	0.000288	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ATIC—epilepsy syndrome	4.05e-06	0.000288	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—UPB1—epilepsy syndrome	4.05e-06	0.000288	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	4.03e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	4.03e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	4.02e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	4.02e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	3.96e-06	0.000282	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	3.96e-06	0.000282	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALAD—epilepsy syndrome	3.92e-06	0.00028	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NT5E—epilepsy syndrome	3.92e-06	0.00028	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	3.89e-06	0.000277	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.83e-06	0.000273	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.83e-06	0.000273	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.82e-06	0.000272	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	3.77e-06	0.000269	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	3.77e-06	0.000269	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	3.76e-06	0.000268	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GBE1—epilepsy syndrome	3.76e-06	0.000268	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	3.74e-06	0.000267	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	3.74e-06	0.000267	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	3.69e-06	0.000263	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.68e-06	0.000262	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	3.66e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	3.63e-06	0.000259	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	3.62e-06	0.000258	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.6e-06	0.000257	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.59e-06	0.000256	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	3.55e-06	0.000253	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	3.54e-06	0.000252	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.52e-06	0.000251	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.48e-06	0.000248	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	3.46e-06	0.000247	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.45e-06	0.000246	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—BCHE—epilepsy syndrome	3.45e-06	0.000246	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	3.44e-06	0.000245	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.41e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.41e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.41e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.41e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.41e-06	0.000243	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	3.36e-06	0.000239	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NT5E—epilepsy syndrome	3.35e-06	0.000239	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALAD—epilepsy syndrome	3.35e-06	0.000239	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	3.29e-06	0.000234	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	3.28e-06	0.000234	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	3.27e-06	0.000233	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.26e-06	0.000232	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	3.25e-06	0.000232	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	3.25e-06	0.000232	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—TH—epilepsy syndrome	3.24e-06	0.000231	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.23e-06	0.00023	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	3.2e-06	0.000228	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	3.2e-06	0.000228	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	3.2e-06	0.000228	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	3.18e-06	0.000226	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.16e-06	0.000225	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.14e-06	0.000223	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	3.13e-06	0.000223	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.12e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.12e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.12e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	3.07e-06	0.000218	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.01e-06	0.000215	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	3.01e-06	0.000214	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.01e-06	0.000214	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2.95e-06	0.00021	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.93e-06	0.000209	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.9e-06	0.000207	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.9e-06	0.000207	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.87e-06	0.000204	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.86e-06	0.000204	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.86e-06	0.000204	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.84e-06	0.000202	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.84e-06	0.000202	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.79e-06	0.000199	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.78e-06	0.000198	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.76e-06	0.000197	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.73e-06	0.000194	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.73e-06	0.000194	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.72e-06	0.000194	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	2.7e-06	0.000193	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.68e-06	0.000191	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CAT—epilepsy syndrome	2.67e-06	0.00019	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.65e-06	0.000189	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.65e-06	0.000189	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.64e-06	0.000188	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.62e-06	0.000187	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—TH—epilepsy syndrome	2.61e-06	0.000186	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	2.6e-06	0.000185	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.59e-06	0.000185	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.59e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.59e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.59e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.57e-06	0.000183	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.56e-06	0.000183	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—TH—epilepsy syndrome	2.56e-06	0.000182	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.47e-06	0.000176	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.47e-06	0.000176	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.42e-06	0.000173	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.42e-06	0.000173	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.42e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	2.41e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.37e-06	0.000169	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.33e-06	0.000166	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.32e-06	0.000165	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.31e-06	0.000165	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.28e-06	0.000162	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.27e-06	0.000162	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.26e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.26e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.25e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.24e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.22e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.21e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	2.18e-06	0.000155	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAT—epilepsy syndrome	2.15e-06	0.000153	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.13e-06	0.000152	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.13e-06	0.000152	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AGT—epilepsy syndrome	2.12e-06	0.000151	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.1e-06	0.00015	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	2.09e-06	0.000149	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOE—epilepsy syndrome	2.07e-06	0.000148	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.07e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.05e-06	0.000146	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.03e-06	0.000144	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.02e-06	0.000144	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.98e-06	0.000141	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.95e-06	0.000139	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.94e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.93e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.93e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.92e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.92e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.91e-06	0.000136	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.9e-06	0.000136	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.9e-06	0.000135	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.87e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.87e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.84e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.83e-06	0.00013	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.82e-06	0.00013	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.82e-06	0.000129	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.81e-06	0.000129	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TH—epilepsy syndrome	1.8e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.78e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.77e-06	0.000126	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.73e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.73e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.71e-06	0.000122	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.67e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.67e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.64e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.64e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.63e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.62e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.56e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.54e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.54e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.52e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.52e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.5e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.5e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.49e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.48e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.48e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.44e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.44e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	1.42e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.4e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.35e-06	9.64e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.34e-06	9.56e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.33e-06	9.5e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.31e-06	9.33e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.28e-06	9.15e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.28e-06	9.12e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.27e-06	9.04e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.27e-06	9.03e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.26e-06	9e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.23e-06	8.79e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.21e-06	8.59e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.19e-06	8.5e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.19e-06	8.46e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.19e-06	8.45e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.18e-06	8.38e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.16e-06	8.28e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.15e-06	8.21e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.15e-06	8.17e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.15e-06	8.17e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.12e-06	7.98e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.01e-06	7.16e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—POMC—epilepsy syndrome	9.99e-07	7.12e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.91e-07	7.06e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—POMC—epilepsy syndrome	9.9e-07	7.05e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOE—epilepsy syndrome	9.85e-07	7.02e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.78e-07	6.97e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.52e-07	6.78e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—epilepsy syndrome	9.1e-07	6.49e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.03e-07	6.43e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.85e-07	6.3e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—POMC—epilepsy syndrome	8.46e-07	6.03e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.97e-07	5.68e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	7.9e-07	5.63e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.76e-07	5.53e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—epilepsy syndrome	7.71e-07	5.5e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.6e-07	5.42e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	7.14e-07	5.09e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	6.75e-07	4.81e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.53e-07	4.65e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.95e-07	4.24e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	5.76e-07	4.1e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.63e-07	4.01e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.21e-07	3.71e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4e-07	2.85e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.97e-07	2.83e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.39e-07	2.42e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.62e-07	1.87e-05	CbGpPWpGaD
